Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells

Marije Veenstra; Peter van Koetsveld; Fadime Dogan - Oruç; WE Farrell; R.A. Feelders; S.W.J. Lamberts; W.W. de Herder; G Vitale; Leo Hofland

doi:10.18632/oncotarget.9462

Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells

Marije Veenstra
, Peter van Koetsveld
, Fadime Dogan - Oruç
, WE Farrell
, R.A. Feelders
, S.W.J. Lamberts
, W.W. de Herder
, G Vitale
, Leo Hofland

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

53 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	14791-14802
Number of pages	12
Journal	Oncotarget
Volume	9
Issue number	19
DOIs	https://doi.org/10.18632/oncotarget.9462
Publication status	Published - 2018

Research programs

EMC MM-01-39-01

Access to Document

10.18632/oncotarget.9462

Cite this

@article{4cf210d044954986ab7ced4e2ea18da4,

title = "Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells",

author = "Marije Veenstra and \{van Koetsveld\}, Peter and \{Dogan - Oru{\c c}\}, Fadime and WE Farrell and R.A. Feelders and S.W.J. Lamberts and \{de Herder\}, W.W. and G Vitale and Leo Hofland",

year = "2018",

doi = "10.18632/oncotarget.9462",

language = "Undefined/Unknown",

volume = "9",

pages = "14791--14802",

journal = "Oncotarget",

issn = "1949-2553",

publisher = "Impact Journals LLC",

number = "19",

}

TY - JOUR

T1 - Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cells

AU - Veenstra, Marije

AU - van Koetsveld, Peter

AU - Dogan - Oruç, Fadime

AU - Farrell, WE

AU - Feelders, R.A.

AU - Lamberts, S.W.J.

AU - de Herder, W.W.

AU - Vitale, G

AU - Hofland, Leo

PY - 2018

Y1 - 2018

U2 - 10.18632/oncotarget.9462

DO - 10.18632/oncotarget.9462

M3 - Article

SN - 1949-2553

VL - 9

SP - 14791

EP - 14802

JO - Oncotarget

JF - Oncotarget

IS - 19

ER -